Overview
- 150 inspections across 134 sites are on record.
- 186 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-11-06.
At a glance
Inspections
150
Sites
134
Observations
186
Career since
Sep 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Jennifer C. Bartczak, M.D. | 6 Nov 2019 | Human Drugs | View 483 → |
| Geoffrey Gotto, M.D. | 16 Aug 2019 | Human Drugs | |
| Carmen Bendezu | 9 Aug 2019 | Human Drugs | |
| Teva Pharmaceutical Industries, Ltd. dba Watson Therapeutics | 27 Jun 2019 | Human Drugs | |
| Jeanne-Elyse G. Cedeno, M.D. | 30 May 2019 | Human Drugs | View 483 → |
Sites inspected
Jennifer C. Bartczak, M.D.Oakland Park, United States1 insp.
Geoffrey Gotto, M.D.Calgary, Canada1 insp.
Carmen BendezuLima, Peru1 insp.
Teva Pharmaceutical Industries, Ltd. dba Watson TherapeuticsMiramar, United States1 insp.
Jeanne-Elyse G. Cedeno, M.D.Pembroke Pines, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Sharon Giamberini11 shared
Ileana Barreto-Pettit6 shared
Jana L Caylor5 shared
Mary F Bodick5 shared
Colleen M Aspinwall4 shared
Paul A Licata3 shared
Tamara J Henderson3 shared
Linda K Matheny3 shared
Brunilda Torres2 shared
Rachel Peters2 shared
Full investigator report
Get the verbatim findings behind Ethan P Stegman's 186 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site